New/Expanded indications - Ezallor Sprinkle (rosuvastatin)

Ezallor Sprinkle (rosuvastatin) - new indications for:

1. primary hyperlipidemia
2. heterozygous familial hypercholesterolemia in adult and pediatric patients 8 years and older
3. cardiovascular event risk reduction, and
4. atherosclerotic cardiovascular disease; expanded indication for homozygous familial hypercholesterolemia in pediatric patients 7 years and older.